Evaluating an Association between Ampicillin and Intraventricular Hemorrhage in Preterm Infants

Eric S Peeples1, Thomas P Strandjord1, Sandra E Juul1

  • 1Department of Pediatrics, University of Washington, Seattle, Washington, United States.

Neuropediatrics
|April 26, 2016
PubMed

Insights

Early ampicillin administration in preterm infants is linked to a higher risk of intraventricular hemorrhage (IVH). Longer ampicillin courses did not show a significant association with IVH development.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Pediatric Neurology

Background:

  • Intraventricular hemorrhage (IVH) is a significant complication in preterm infants, affecting up to 30%.
  • Beta-lactam antibiotics, like ampicillin, can influence platelet function, a factor relevant to bleeding events such as IVH.

Purpose of the Study:

  • To investigate the association between ampicillin use and the incidence of intraventricular hemorrhage in preterm infants.
  • To determine if the timing and duration of ampicillin administration correlate with IVH development.

Main Methods:

  • A retrospective case-control study involving preterm, low-birth-weight infants with and without IVH.
  • Conditional logistic regression analysis of 10 clinical features from the first week of life.
  • Data collected from 174 subjects, with matched controls for demographic factors and illness severity.

Main Results:

  • Earlier initiation of ampicillin was significantly associated with increased odds of developing IVH (OR: 0.95, p=0.028).
  • No significant association was found between longer durations of ampicillin therapy and the development of IVH (OR: 1.13, p=0.089).

Conclusions:

  • The timing of ampicillin administration, specifically earlier use, appears to be a risk factor for IVH in preterm infants.
  • Further research is warranted to explore the impact of ampicillin's dose, timing, and duration on IVH outcomes.

Related Concept Videos